(Ebook PDF) Pubertal Suppression in Transgender Youth 1st Edition by Courtney Finlayson ISBN 9780323569644 0323569641 full chapters

(Ebook PDF) Pubertal Suppression in Transgender Youth 1st Edition by Courtney Finlayson -Ebook PDF Instant Download/Delivery:9780323569644, 0323569641

Instant download Full Chapter of Pubertal Suppression in Transgender Youth 1st Edition after payment

Product details:

ISBN 10:0323569641

ISBN 13:9780323569644

Author: Courtney Finlayson

Offering current guidelines on the relatively new practice of puberty suppression for gender-dysphoric adolescents, Pubertal Suppression in Transgender Youth provides a succinct, easy-to-digest overview of this timely topic. This concise, clinically-focused resource by Dr. Courtney Finlayson covers all relevant topics, from a brief history of medical care of transgender youth to emerging developments in the field.

• Covers the use of gonadotropin-releasing hormone agonist (GnRHa) therapy in transgender youth, including models of care and current treatment guidelines, fertility issues, ethical considerations and the consent process, and more.

• Discusses psychosocial, medical, and surgical side effects of treatment.
• Consolidates today’s available information on this timely topic into one convenient resource.

Table of Contents:

• Chapter 1. History of Care of Transgender Youth
• Dedication
• Chapter 2. Models of Care and Current Guidelines for Care of Transgender Individuals
• Gender-Affirming Care
• Multidisciplinary Care
• Practice Guidelines
• Mental Healthcare
• Medical Care
• Adjunctive Services
• Barriers to Care
• Summary
• Chapter 3. Puberty
• Physical Changes Associated With Puberty
• Physiology of Puberty
• Delayed Puberty or Absent Puberty (Sexual Infantilism)
• Precocious Puberty (Sexual Precocity)
• Chapter 4. GnRH Analogs (Mechanism, Past Studies, Drug Options, Use in Precocious Puberty, Use in Gender-Nonconforming Youth)
• Historical Perspective
• Physiology and Mechanism of Action
• Use in Central Precocious Puberty
• Outcomes in Central Precocious Puberty
• Use in Gender-Nonconforming Youth
• Options for Treatment
• Outcomes in Gender-Nonconforming Youth
• Challenges in Care
• Conclusion
• Chapter 5. Rationale for the Initiation, Use, and Monitoring of GnRHa in Gender Non-conforming Youth
• Introduction
• Rationale
• Initiation
• Monitoring
• Conclusion
• Chapter 6. Psychosocial Considerations in Pubertal Suppression Treatment
• Introduction
• Possible Effects of Gonadotropin-Releasing Hormone Analogues on Gender Identity and/or Sexuality Development
• Unknown Neurocognitive Sequelae of Pubertal Suppression Treatment
• Psychosocial Implications of Known Medical Side Effects of Gonadotropin-Releasing Hormone Analogue Treatment
• Family Factors
• Conclusion
• Chapter 7. Medical Side Effects of GnRH Agonists
• Bone Health
• Brain
• Fertility
• Body Mass Index and Body Composition
• Summary
• Chapter 8. Surgical Side Effects of GnRHa
• Introduction
• Goals of Surgery
• Timing of Surgery
• Surgical Considerations for Individuals on GnRHa
• Areas of Uncertainty
• Conclusion
• Chapter 9. Fertility Preservation: Considerations for Gender-Diverse Youth
• Risk of Infertility due to Hormonal Therapies
• Fertility Preservation Options in Birth-Assigned Males
• Fertility Preservation Options in Birth-Assigned Females
• Attitudes Toward FP and Other Psychological Considerations
• Ethical Considerations
• Financial Considerations
• Future Directions
• Conclusions
• Chapter 10. Duration of Pubertal Suppression and Initiation of Gender-Affirming Hormone Treatment in Youth
• Pubertal Suppression and Gender-Affirming Hormone Therapies
• Relevant Time Points in Clinical Guidelines and Protocols
• Unresolved Questions
• Case Examples
• Initiation of Gender-Affirming Hormones
• Testosterone
• Estrogen
• Conclusions
• Chapter 11. Ethical Considerations of GnRHa Treatment and Consent Process
• Introduction
• Pubertal Suppression
• Benefits of Pubertal Suppression
• Ethical Issues
• Conclusion
• Chapter 12. Emerging Developments in Pubertal Suppression for Gender Incongruent/Gender Dysphoric Youth
• Triptorelin, a New Gonadotropin-Releasing Hormone Agonist
• Prolonged Use of Histrelin acetate implant in Transgender Youth
• Gonadotropin-Releasing Hormone Agonist Use in Nonbinary Youth
• Gonadotropin-Releasing Hormone and Gonadotropin Antagonists
• Kisspeptin and Neurokinin B Antagonists
• Oxandrolone as an Alternative Gender-Affirming Masculinizing Hormone
• Low-Dose Estrogen and Testosterone
• Antiandrogens and Androgen Receptor Inhibitors
• Antiandrogens
• Conclusion

People also search:

pubertal suppression for transgender youth and risk of suicidal ideation
pubertal suppression
puberty suppression definition
puberty suppression drugs
puberty suppressants

Tags:

Courtney Finlayson,Pubertal Suppression,Transgender Youth